Navigation Links
Sorrento Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference in New York City
Date:5/30/2013

SAN DIEGO, May 30, 2013 /PRNewswire/ -- Sorrento Therapeutics (OTCBB: SRNE; or STI) today announced that Henry Ji , Ph.D., the Company's President and Chief Executive Officer, will present at the Jefferies 2013 Global Healthcare Conference on Thursday, June 6th, 2013, at 3:00 PM ET. The conference will be held at the Grand Hyatt in New York, NY.

A live webcast of the presentation will be available at the start time of the presentation by accessing http://wsw.com/webcast/jeff77/srne/. Following the live presentation, a replay of the webcast will be available for 90 days.

About Sorrento Therapeutics

Sorrento Therapeutics, Inc. is a publicly-traded, development-stage biopharmaceutical company focused on the acquisition, discovery, development and commercialization of novel and proprietary biotherapeutics for the treatment of a variety of disease conditions, including cancer, inflammation, metabolic and infectious diseases. STI's objective is to identify drug development candidates derived from its proprietary human antibody libraries and, either independently or through partnerships, advance selected targets into preclinical or clinical development. In 2012, STI identified and further developed a number of potential drug product candidates across various therapeutic areas. STI intends to select several lead product candidates to progress into preclinical development activities in 2013, including human anti-PD-L1 and anti-PD-1 monoclonal antibodies (mAbs) that have demonstrated strong immunomodulatory activity in vitro comparable to competitor mAbs currently in clinical development as well as significant anti-cancer activity in a tumor mouse model.

Forward-Looking Statements

This press release contains forward-looking statements subject to risks and uncertainties that could cause actua
'/>"/>

SOURCE Sorrento Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sorrento Therapeutics Awarded Third Phase I STTR Grant
2. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
3. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
6. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014  Elusys Therapeutics, ... to treat infectious disease, today announced it has ... studies of obiltoxaximab (ETI-204). Obiltoxaximab is an anti-toxin ... and data from these studies support the safety ... (IV) at the intended therapeutic dose. The conclusion ...
(Date:9/22/2014)...  Aethlon Medical, Inc. (OTCQB: AEMD), the pioneer ... disease, cancer and other life-threatening conditions, disclosed today ... has informed the Company that it plans to ... of a five-year $5.9 million contract that was ... DARPA,s Dialysis-Like Therapeutics (DLT) program. The ...
(Date:9/22/2014)... 2014 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products, is pleased to announce that ... signed a definitive lease agreement for a second facility ... facility has 28,966 square feet of floor space with ... mezzanine space for a total of approximately 43,500 square ...
Breaking Medicine Technology:Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3
...  PAREXEL International Corporation (NASDAQ: PRXL ) today ... March 31, 2012. For the three months ... by 18.1% to $356.0 million compared with $301.4 million ... negative impact from foreign exchange on consolidated service revenue ...
... Mass., April 29, 2012  Haemonetics Corporation (NYSE: ... acquire the business assets of the blood collection, filtration ...  Blood processing systems and equipment to be acquired are ... facilities in Covina, California; Tijuana, Mexico; Ascoli, Italy and ...
Cached Medicine Technology:PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 2PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 3PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 4PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 5PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 6PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 7PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 8PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 9PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 10PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 11PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 12PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 13Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 2Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 3Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 4Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 5
(Date:9/23/2014)... Recently, BuyTopDress.com, a popular supplier of wedding dresses and special ... fashionable marine ball dresses . Along with this, the ... brand new items; all of them are now provided with ... now, BuyTopDress.com has won more than 2000 happy customers in ... its products and after-sale services. The company is offering thousands ...
(Date:9/22/2014)... September 23, 2014 The Gesundheit! Institute ... a new design and restructuring for their existing website. The ... grown. They needed a way to navigate to the different ... well as present the look and feel of the site ... In 1971, when Patch Adams graduated from The Medical School ...
(Date:9/22/2014)... leather seat covers offered by Lseat.com are meticulously in ... to meet customers’ specific product needs and budget level. The ... leather seat covers . Furthermore, the firm has launched an ... the new range is now available at a discounted rate ... are produced, the company’s top designers also carefully pick out ...
(Date:9/22/2014)... Career Step, an online provider of ... and exhibiting at the 86th Annual Convention and ... (AHIMA) in San Diego, California. The conference is ... Career Step will be exhibiting in booth 711 ... products, including CLiM™, its coder lifecycle management solution, ...
(Date:9/22/2014)... Marietta, GA (PRWEB) September 23, 2014 The ... staff are helping to promote National Breast Cancer Awareness ... intend to contribute awareness to cause, prevention, diagnosis, treatment and ... in dental offices across the U.S. , A pink ... the person that can tell us why the Sonicare is ...
Breaking Medicine News(10 mins):Health News:Fashionable Marine Ball Dresses Added To BuyTopDress.com’s Collection 2Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 2Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 3Health News:Great 2007-2012 Jeep Wrangler JK Real Leather Seat Covers Introduced by Lseat.com 2Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Verde Pointe Dental Associates Participate in Breast Cancer Awareness Month 2014 with a Pink Philips Sonicare Giveaway 2
... ... workplace culture to empower professional women to breastfeed , ... Sacramento, CA (PRWEB) May 10, 2010 -- Is the primitive fear ... ,That is one premise a California startup, Dao Health, is contributing to the public conversation ...
... ill and participate in mild exercise programs led by ... days in intensive care units (ICU) and hospitals than ... published in the April issue of the Archives ... quality improvement project implemented in a medical intensive care ...
... physical abuse alone, study found , MONDAY, May 10 (HealthDay ... women who are exposed to physical and verbal abuse have ... up in the results, study author Dr. Charles P. Mouton ... physical abuse alone. , Why? "The physical abuse may be ...
... pressure are at even greater risk, study finds ... have fluctuating blood pressure in addition to high blood ... research shows. , Cerebrovascular disease, which includes stroke and ... associated with disability and a decline in memory and ...
... sibling has the movement disorder, study shows , MONDAY, May ... who have restless legs syndrome are also more likely to ... authors of the study, which is published in the May ... will raise awareness of the condition for both physicians and ...
... The lawsuit, ... some 30,000 health care workers, treats visiting nurses and other health care providers as exempt ... hours worked. , ... NY (PRWEB) May 10, 2010 -- A nationwide class action lawsuit was filed ...
Cached Medicine News:Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 2Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 3Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 4Health News:Physical therapist-led exercise in patients in ICU improves function and decreases hospital stay 2Health News:Older, Abused Women Suffer Poor Mental Health 2Health News:Fluctuating Blood Pressure Ups Stroke Risk 2Health News:Restless Legs Syndrome Can Have Family Ties 2Health News:Martin & Jones Announces Class Action Lawsuit Against Major Employer, Claims Thousands of Visiting Nurses Illegally Denied Overtime Pay 2Health News:Martin & Jones Announces Class Action Lawsuit Against Major Employer, Claims Thousands of Visiting Nurses Illegally Denied Overtime Pay 3
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTP/1Q-PAL chairs are recommended for the ... room, static control, health care and ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTP/1Q-PAL chairs are recommended for the ... room, static control, health care and ...
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTN/1Q-CAB chairs are recommended for the ... room, static control, health care and ...
Medicine Products: